Answers are grounded in this paper and cite their sources.
Viral infections remain a significant cause of morbidity and mortality after hematopoietic stem cell transplantation. Pharmacologic agents are effective against some pathogens, but they are costly and can be associated with significant toxicities. Thus, many groups have investigated adoptive T-cell transfer as a means of hastening immune reconstitution and preventing and treating viral infections. This review discusses the immunotherapeutic strategies that have been explored.
No takes yet. Share an insight, caveat, or question.
Tzannou et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: